A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/56 (2006.01) A61K 31/175 (2006.01)
Patent
CA 2580606
The present invention is directed to therapeutic compositions targeting the NCCa_ATPchannel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, antagonists of the NCCa_ATPchannel are contemplated. The compositions are used to prevent cell death and to treat secondary damage associated with spinal cord injury.
Cette invention concerne des compositions thérapeutiques ciblant le canal NCCa_ATP d'une cellule astrocyte, d'une cellule nerveuse ou d'une cellule endhothéliale capillaires et leurs procédés d'utilisation. L'invention porte plus particulièrement sur des antagonistes de canal NCCa_ATP . Les compositions sont utilisées pour lutter contre la mort cellulaire et pour traiter les dommages secondaires relatifs aux lésions de la moelle épinière.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The United States Of America As Represented By The Department Of
University Of Maryland Baltimore
LandOfFree
Therapeutic agents targeting the ncca-atp channel and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agents targeting the ncca-atp channel and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents targeting the ncca-atp channel and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1867101